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Abstract
Both OTX2 and MYC are important oncogenes in medulloblastoma, the most common malignant brain tumor in childhood.
Much is known about MYC binding to promoter regions, but OTX2 binding is hardly investigated. We used ChIP-on-chip
data to analyze the binding patterns of both transcription factors in D425 medulloblastoma cells. When combining the data
for all promoter regions in the genome, OTX2 binding showed a remarkable bi-modal distribution pattern with peaks
around 2250 bp upstream and +650 bp downstream of the transcription start sites (TSSs). Indeed, 40.2% of all OTX2-bound
TSSs had more than one significant OTX2-binding peak. This OTX2-binding pattern was very different from the TSS-centered
single peak binding pattern observed for MYC and other known transcription factors. However, in individual promoter
regions, OTX2 and MYC have a strong tendency to bind in proximity of each other. OTX2-binding sequences are depleted
near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding. This contrasts
to the enrichment of E-box sequences at TSSs. Both OTX2 and MYC binding independently correlated with higher gene
expression. Interestingly, genes of promoter regions with multiple OTX2 binding as well as MYC binding showed the
highest expression levels in D425 cells and in primary medulloblastomas. Genes within this class of promoter regions were
enriched for medulloblastoma and stem cell specific genes. Our data suggest an important functional interaction between
OTX2 and MYC in regulating gene expression in medulloblastoma.
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Introduction
OTX2 encodes a homeodomain containing transcription factor,
which is essential for normal brain development. In the
cerebellum, OTX2 is expressed in progenitor cells, but only at
pre-natal stages. In post-natal cerebellum, no OTX2 expression
can be detected [1]. However, the malignant childhood brain
tumor medulloblastoma, which originates in the cerebellum, often
expresses OTX2 at high levels [1–5]. These high OTX2 levels
together with amplification or gain of the OTX2 locus in a subset
of the tumors suggest an oncogenic role for OTX2 in
medulloblastoma [3,4,6,7].
Indeed, we and others have shown a dependency on OTX2
for medulloblastoma cells with OTX2 expression [7,8]. Cells in
which we silenced OTX2 expression were inhibited in
proliferation and started to differentiate [8]. Expression profiling
after induction of ectopic OTX2 or silencing endogenous OTX2
in medulloblastoma cell lines revealed over 2000 genes regulated
downstream of OTX2, including many cell cycle and eye
developmental genes [8,9]. ChIP-on-chip analyses identified cell
cycle genes as major direct targets of OTX2, while differenti-
ation genes, strongly regulated after OTX2 silencing, appeared
to be indirect targets.
Although OTX2 is an essential gene in medulloblastoma, little
is known about the mechanism by which OTX2 regulates the
expression of its target genes. Only in a few studies interaction of
OTX2 with other gene expression regulators have been reported.
These studies mainly focused on the regulation of a single target
gene [10–15]. Early studies used limited promoter regions or
oligonucleotides to assess OTX2 binding and they identified
TAATCC and related sequences as the main DNA-binding motif
for OTX2 [16–21].
In this study, we have analyzed the binding of OTX2 to
promoter regions in the complete genome and compared the
OTX2 data with ChIP-on-chip data for MYC in medulloblas-
toma. MYC is another important oncogene in medulloblastoma
pathogenesis and high-level amplifications of the MYC locus are
significantly associated with a poor clinical outcome [22–25]. Our
analyses show that 40.2% of all OTX2 bound promoter regions
contain multiple OTX2-binding peaks, while the other 59.8%
showed only single OTX2 binding. Together they contribute to a
specific bi-modal distribution of OTX2 binding near TSSs. The
distribution of OTX2-binding motifs provided a possible
explanation for the bi-modal distribution as these motifs were
depleted near TSSs in the genome. MYC binding displayed a
distribution centered on the TSS, similar to other studies [26,27].
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with higher gene expression. The highest expression levels were
found for genes with multiple OTX2-binding peaks plus MYC
binding. These genes, but not the genes with single OTX2
binding or the genes with multiple OTX2 binding and no MYC,
were enriched for medulloblastoma and stem cell specific genes.
Furthermore, OTX2 and MYC bind closer to each other in
promoter regions than would have been expected if binding
occurred randomly. Together these results suggest that OTX2
and MYC cooperate in regulating gene expression in medullo-
blastoma.
Results
OTX2 shows unique DNA-binding pattern in
medulloblastoma cell lines
To investigate OTX2 binding, we examined where OTX2
binds in promoter regions. Data from our OTX2 ChIP-on-chip
(Nimblegen promoter arrays) experiment in D425 cells were used
[8]. To get a global overview of OTX2 binding we aligned all
promoter regions according to the position of the transcriptional
start sites (TSSs) and per bin of 50 bp we calculated the average
OTX2-binding signal for all promoters together. The results
revealed a bi-modal distribution of OTX2 binding in promoter
regions with peaks around 2250 bp upstream and +650 bp
downstream from the TSSs (Figure 1A).
A similar bi-modal distribution was found when only
considering the significant binding peaks (as called by the
Nimblegen algorithm). We plotted these data as the percentage
of all promoter regions with a significant binding peak and
observed a similar bi-modal distribution (Figure 1B). The two
control ChIP-on-chip experiments, in which we omitted the
OTX2 antibody or used a FLAG antibody instead, did not show
this pattern. A similar bi-modal distribution of OTX2 binding
was also observed when we used ChIP-on-chip data of MED8A
and DAOY medulloblastoma cells with ectopic OTX2 expression
(Figure 1C and Figure S1) [9].
As this OTX2 binding distribution strongly differs from the
TSS-centered single peak pattern commonly found for transcrip-
tion factors, we performed another ChiP-on-chip experiment for
MYC, which is like OTX2 also amplified and highly expressed in
D425 cells (Figure S1). Data from this ChIP-on-chip experiment
showed that the MYC binding, calculated over all promoter
regions, is concentrated in a single peak centered on the TSS
(Figure 1D), in line with previous reports for MYC in other cell
systems [26,27].
To investigate whether the bi-modal distribution of OTX2
implies multiple OTX2 binding peaks per gene, we calculated
the number of significant OTX2-binding peaks per promoter
region. As a result, 40.2% of the 11,389 promoter regions with
OTX2 binding had two or more significant OTX2-binding
peaks, and the remaining 59.8% had a single OTX2-binding
peak. For both single and multiple OTX2-bound promoter
regions the widths of the peaks were similar. The promoter
regions with multiple OTX2 binding displayed again the bi-
modal distribution pattern (Figure 1E and 1F). Even when
correcting for overlapping promoter regions, a bi-modal pattern
remained. In single bound promoter regions, there was a less
prominent bi-modal distribution (Figure 1E and 1F). However,
the distribution of single OTX2-bound promoters did not
resemble the MYC-binding pattern, which is TSS-centered.
Therefore, the overall bi-modal distribution seems not caused by
multiple OTX2 binding alone, but a general tendency of OTX2
to bind adjacent to the TSS.
OTX2 and MYC bind close to each other in promoter
regions
As both OTX2 and MYC bind to many genes in the genome
[8,26–28], we examined to what extent OTX2 and MYC bind
the same promoter regions. Out of 25,064 promoter regions
present on the Nimblegen chip, 11,389 (45.4%) had one (6,811)
or more (4,578) OTX2-bindingp e a k sw i t h i n2k bo ft h eT S S .
MYC-binding was detected for 12,906 (51.5%) promoter
regions and 6,240 (24.9%) had both OTX2 and MYC binding.
The most significant overlap was found for promoter regions
with multiple OTX2-binding peaks. Of these, 63.8% (2,923 of
4,578) also had MYC binding (p=6.9*E-78 hypergeometric
test compared to all promoter regions). For promoter regions
with a single OTX2-binding peak, we detected MYC binding
in 48.7% (3,317 of 6,811) of the cases. Hence, based on the
amount of OTX2-binding peak and MYC binding, four
Figure 1. OTX2 binding reveals a bi-modal distribution
surrounding transcription start sites. A. Graphical representation
of the average
2log signal of OTX2 ChIP-on-chip data in D425
medulloblastoma cells (green line) as a function of the distance to
the transcription start site (TSS). OTX2 binding displays a bi-modal
distribution, which is absent in the controls using a FLAG or no
antibody (blue and red line, respectively). B. The percentage of
promoter regions with OTX2-binding peaks were plotted as a function
of the distance to the TSS. This also shows a bi-modal distribution of
OTX2. C. A bi-modal distribution of OTX2 binding was also found using
OTX2 ChIP-on-chip data from MED8A and DAOY medulloblastoma cell
lines with ectopic OTX2 overexpression (red and blue lines, respective-
ly). MED8A cells without OTX2 (green line) did not show this pattern. D.
Average MYC binding in D425 cells peaks at the TSS. E. Average OTX2-
binding signal plotted separately for promoter regions with single (red
line) or multiple OTX2-binding peaks (blue line). F. Percentage of bound
promoters as a function of the distance from the TSS for promoters with
single OTX2-binding peaks (red line) and promoters with multiple
OTX2-binding peaks (blue line).
doi:10.1371/journal.pone.0026058.g001
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single OTX2-bound promoter regions with or without MYC
binding and multiple OTX2-bound promoter regions with or
without MYC binding.
Figure 2 shows the OTX2-binding peaks for all four possible
combinations of OTX2 and MYC binding to promoter regions
with OTX2 binding. Two classes have single OTX2-binding
peaks with or without MYC binding (Figure 2A), while the other
two classes have multiple OTX2 peaks with or without MYC
binding (Figure 2B). Per class the promoter regions were sorted
according to the location of the first OTX2 binding peak,
starting with the most upstream peak. Strikingly, when we
depicted the MYC-binding peaks for these same promoter
regions (Figure 2A and 2B, right panels), we observed that the
MYC-binding peaks closely follow the OTX2-binding pattern.
This was most clear for the class of promoter regions with single
OTX2-binding peaks, but even for the class of promoter regions
with multiple OTX2 binding the MYC-binding peaks tend to
accumulate in the same areas. Reversely, when viewing from the
MYC binding perspective, OTX2 binding follows MYC binding
particularly when closer to the TSS (Figure S2). These data
suggest a frequent co-localization of both transcription factors
on the promoter. Furthermore, when comparing the calculated
distance between OTX2 and MYC-binding peaks to the
expected distance (Figure 2C) OTX2 and MYC bind closer to
each other in promoter regions then expected. However, they
do not occupy the exact same location. MYC preferably binds
near or at the TSS, while OTX2b i n d i n gt e n d st ob em o r e
adjacent to the TSS.
OTX2 binding motifs are depleted near the TSSs
We investigated whether the observed bi-modal distribution of
OTX2 binding relates to DNA-binding motifs. Therefore, we
performed Discriminating Motif Enumerator (DME) analyses of
the regions bound by OTX2 to discover binding motifs over-
represented within the OTX2-binding peaks [29]. TAATCC
turned out to be the most over-represented sequence, followed by
the related TAAGCC and TAATCT sequences (Table S1A). The
four different promoter classes all showed a similar frequency for
these sequences. These same sequences were also enriched in the
OTX2-bound sequences identified in MED8A cells with overex-
pression of ectopic OTX2 (Table S1B). Similar analyses identified
known E-box sequences as the main binding motifs in MYC-
bound regions (Table S1C). All OTX2 and MYC motifs were
enriched in the centers of binding peaks (Figure 3A). We also
analyzed the distribution of these OTX2- and MYC-binding
motifs in promoter regions. Surprisingly, all three OTX2 motifs
were depleted near the TSSs, while E-box sequences were
enriched (Figure 3B, blue lines). As TAATCC and related
sequences are enriched in Alu repeats, these analyses were
repeated with a repeat mask. However, OTX2 motifs still did
not peak at the TSSs, while E-box sequences remained enriched
(Figure 3B, red lines). Thus, the bi-modal distribution of OTX2
binding might be caused by the depletion of OTX2-binding motifs
near the TSSs.
Binding of OTX2 and MYC is associated with increased
gene expression
To assess whether OTX2 or MYC binding is related to gene
expression, we depicted the OTX2- and MYC-binding peaks for
each promoter region and sorted the promoter regions according
to the gene expression levels as established by Affymetrix
expression profiling of D425 cells [8]. Figure 4A (left panel)
shows a correlation between the amount of OTX2-binding peaks
and gene expression levels. The promoters of highly expressed
genes showed more signal. The panel on the right in Figure 4A
shows similar data for MYC. Like OTX2, MYC binding
correlates with gene expression levels. This is also demonstrated
in Figure 4B, in which the percentage of all promoter regions that
have a OTX2- or MYC- binding peak at the indicated position
are plotted. Promoter regions were divided into five categories
based on increasing gene expression levels in D425 cells. For both
OTX2 and MYC, the percentage of promoter regions with a
binding peak increased with increasing expression levels. The bi-
modal OTX2 and the TSS-centered MYC- binding patterns do
not differ between the different expression categories. Thus, both
OTX2 and MYC binding are associated with increased gene
expression.
OTX2 binding motifs do not correlate with expression
levels
As OTX2 binding correlates with gene expression, we
wondered whether the usage of the different OTX2-binding
motifs influenced gene expression levels. However, the more
highly expressed genes showed no enrichment for any OTX2-
binding motifs in their promoter regions (Figure 5). The
presence of a motif also had no effect on the number of genes
regulated or the magnitude of the regulation after OTX2
silencing in D425 cells (data not shown). Therefore, even though
these motifs are required for OTX2 binding, additional factors
seem to be necessary to determine expression levels and
regulation.
Genes with multiple OTX2 and MYC binding are
expressed at higher levels in medulloblastoma and stem
cells
We then investigated whether the four different classes of
promoter regions with OTX2 and MYC binding as depicted in
Figure 2 show differences in gene expression levels. Interest-
ingly, the most striking correlation was found for the class of
promoter regions with multiple OTX2-binding peaks with
MYC binding (Figure 6A; blue line). In D425 cells, with
increasing expression the percentage of promoter regions that
have multiple OTX2 and MYC binding also increased.
Therefore, genes with a promoter region from this class were
much more abundant in the high expression categories. Genes
with promoter regions from the other classes, i.e. with single
OTX2-binding peaks with or without MYC binding or with
multiple OTX2-binding peaks without MYC binding, were
more or less equally distributed over all expression categories
( F i g u r e6 A ) .W ef o u n dt h es a m ec o r r e l a t i o nb e t w e e nO T X 2 /
MYC binding and gene expression when we used expression
data of medulloblastoma tumors [5,30] (Figure 6B). These
results suggest that multiple OTX2 and MYC binding have a
synergistic effect on gene expression.
Surprisingly, however, there was no relation between the four
classes of promoter regions and gene regulation after OTX2
silencing in D425 cells [8]. The percentage of regulated genes
(ranging from 15 to 18%) was more or less equal between the four
classes. Furthermore, Gene ontology analyses did not reveal any
differences in molecular function between the genes in these four
classes. In contrast, gene set enrichment analyses (GSEA), using
either DAVID [31] or the BROAD tools [32,33], revealed that
genes with multiple OTX2-binding peaks and MYC binding were
significantly enriched for genes associated with mouse (neuronal)
stem cells [34] and human medulloblastoma [35] (Table S2). The
other groups did not show such enrichments.
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promoter regions and medulloblastoma/stem cell specific expres-
sion. The average expression levels of genes from the class with
both multiple OTX2-binding peaks and MYC binding were
consistently higher in medulloblastoma and human neuronal stem
cells as compared to genes from other classes (Figure 6C). This
difference was not present in normal cerebellum. These data
suggest that genes with multiple OTX2-binding peaks and MYC
binding in their promoter region may have specific functions in
medulloblastoma and/or stem cells.
Discussion
The specific bi-modal distribution of OTX2 binding around the
TSSs, as we investigated in medulloblastoma, strongly differs from
the binding patterns of MYC and other transcription factors like
Figure 2. OTX2 and MYC bind close to each other in promoter regions. For each of the four classes of promoter regions, the
2log binding
signals of OTX2- and MYC-binding peaks are shown. Promoter regions are sorted by the location of the first upstream OTX2-binding peak. A. Both
classes with a single OTX2-binding peak have a very similar OTX2-binding pattern. When MYC is also bound the MYC-binding peaks closely follow the
OTX2 pattern. B. Promoter regions with multiple OTX2-binding peaks. MYC-binding peaks again accumulate there where OTX2 is bound. C. The
distances between OTX2- and MYC-binding peak centers were calculated for all promoter regions with single OTX2 binding with MYC binding. The
percentage of OTX2-binding peaks within different distance ranges was plotted. Data show that significantly more peaks are close to each other
(within 400 bp from each other) then expected (* ,0.05, ** ,0.0005, Fisher’s exact test). Expected distance was generated by multiple randomization
of the OTX2 position.
doi:10.1371/journal.pone.0026058.g002
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was observed both in cells with endogenous OTX2 expression
(D425) as well as in cells with induced transgene expression
(MED8A and DAOY).
The bi-modal distribution consists both of promoter regions
with single and multiple OTX2-binding peaks. The class of
promoter regions with both multiple OTX2-binding peaks with
MYC binding differed from the other classes, as they were
associated with higher gene expression in D425 medulloblastoma
cells and in primary medulloblastoma tumors. Moreover, genes
within this class of promoter regions were enriched for stem cell
and medulloblastoma specific gene expression. Thus, OTX2
seems to have a functional interaction with MYC, which might
explain why both genes are frequently co-expressed at high levels
in medulloblastoma [5,6,22].
Even though the binding pattern might be specific for OTX2,
other binding properties were consistent with those found for
MYC in D425 cells or from what has been described for other
transcription factors [26,27,36–38]. Similar to genes as MYC or
OCT4, OTX2 binds to a large number of genes [26,39]. This
frequent binding does not always result in gene regulation, as
usually only for around a third or less of the bound genes the
expression levels change after overexpressing or silencing the
transcription factor [40]. We obtained similar results in OTX2
silencing and ectopic overexpression experiments [8,9].
The relation between transcription factors binding to promoter
regions and gene expression can be biased by the methods used to
Figure 3. OTX2 motifs enriched at OTX2 peak centers, but not
at TSSs. A. The percentage of the OTX2-binding motifs (TAATCC,
TAAGCC and TAATCT) per 50 bp were plotted in regards to the OTX2-
binding peak center. For all three motifs, enrichment at the center of
OTX2-binding peaks is observed, although for TAATCC this was more
apparent in repeat masked data (red) compared to unmasked data
(blue). Similar results were obtained for the E-box sequences in the MYC
experiment. B. The presence of OTX2- and MYC-binding motifs was
scored per 50 bp for all promoter regions in the genome. While E-box
sequences display a higher frequency near TSSs in the genome,
TAATCC, TAAGCC and TAATCT do not. They all show a clear depletion
near TSSs, which is most clear in data without repeat mask (blue lines)
as compared to data with repeat mask (red lines).
doi:10.1371/journal.pone.0026058.g003
Figure 4. Both OTX2 and MYC binding correlate with high gene
expression. A. All individual promoter regions were ordered by
expression level of the associated gene in D425 cells and the
corresponding
2log binding signals of OTX2 and MYC in D425 cells
were visualized. Both OTX2 and MYC binding positively correlates with
gene expression. B. All promoter regions were categorized into five
categories by
2log expression values of the corresponding genes. With
increasing expression the percentage of bound promoter regions also
increases both for OTX2 and MYC. Overall distribution patterns do not
change.
doi:10.1371/journal.pone.0026058.g004
OTX2 and MYC Binding Links to High Gene Expression
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bound regions to the nearest known genes might be inadequate. It
disregards many other forms of gene regulation by, for instance,
enhancers, which can be located far away from a gene [40].
Secondly, silencing of a transcription factor is commonly used to
identify its target genes. The transcription factor levels are greatly
Figure 5. OTX2-binding motifs do not correlate with gene expression levels. All OTX2-binding peaks were sorted by the expression in D425
cells of the associated genes and binned per 400. The motif frequency for each bin is displayed as a function of average expression. For all three
OTX2-binding motifs, there is no relation between gene expression levels and motif occurrence within the peaks.
doi:10.1371/journal.pone.0026058.g005
Figure 6. Multiple OTX2-binding peaks with MYC binding is associated with high gene expression. A and B. OTX2-bound promoter
regions are classified by single or multiple OTX2-binding peaks with or without additional MYC-binding. For each of these promoter classes the
percentage of bound promoter regions was calculated in different expression categories using either expression data from D425 cells (A) or
expression data from 10 primary medulloblastoma tumors that have both OTX2 and MYC expression (B). Promoter regions with multiple OTX2-
binding peaks and MYC binding were clearly enriched among the gene categories that show higher gene expression both in D425 cells and in
tumors. C. Genes within the promoter class with multiple OTX2-binding peaks and MYC binding showed significantly higher expression levels in D425
cells, primary medulloblastoma tumors and human neural embryonic stem cells as compared to genes in other classes (minimal p,1.00E-7, T-test).
This difference was not observed using expression data of normal cerebellum.
doi:10.1371/journal.pone.0026058.g006
OTX2 and MYC Binding Links to High Gene Expression
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might be sufficient to retain expression. Together this could hinder
adequate interpretation of the effect of OTX2 binding on gene
regulation.
Furthermore, binding might not result in regulation, because
multiple transcription factors are required in order to regulate
gene expression. For instance, in mouse embryonal stem cells,
transcription factors as Oct4, Sox2 and Nanog all bind up to
10,000 genes each. However, only a small number of genes bound
by all three factors showed evidence of direct transcriptional
activation by these transcription factors [39]. A similar mechanism
may be envisioned for OTX2. An obvious candidate to interact
with OTX2 to activate gene expression is MYC, even though it is
not expressed in all OTX2-expressing tumors. Genes with
combined multiple OTX2-binding peaks and MYC binding have
the highest expression in medulloblastoma. However, these genes
were not significantly more regulated after OTX2 silencing,
suggestion other transcription factors are also involved.
Direct physical interaction between OTX2 and MYC could not
be established (data not shown). Other candidates for cooperative
binding with OTX2 are scarce as little is known about protein
complexes associated with OTX2. Physical interactions with other
transcription factors, like TLE4 and MEIS2, have been reported
[10,12]. Both these genes are expressed in medulloblastoma
tumors and cell lines. Interestingly, a MEIS2 like motif,
TGACAG, was among the enriched motifs within genes down-
regulated after OTX2 silencing. Thus, MEIS2 might be necessary
to specify the binding and/or biological function of OTX2 in
medulloblastoma. Other proteins with reported physical interac-
tion with OTX2 are less likely candidates. For instance MITF,
SOX2, LHX1 and FOXA2, show only limited expression in
tumors and are absent in D425 cells [11,14,15]. However,
structural or functional related genes might substitute for them
in medulloblastoma. The GSEA analyses for genes with multiple
OTX2-binding peaks and MYC binding in their promoter region
also showed enrichment for the SP1, NFY and MAZ binding
motifs (Table S2). As these genes are highly expressed in
medulloblastoma, they may also interact with OTX2 to regulate
gene expression.
The role of DNA-binding sequences in the function of
transcription factors remains unclear. For OTX2, TAATCC,
TAAGCC and TAATCT are the most enriched binding motifs in
medulloblastoma, in accordance with literature [16–21]. However,
like for other transcription factors, the prevalence of these binding
motifs in the genome exceeds the number of detected binding.
Also the distribution near the TSSs is not predictive for OTX2-
binding pattern, as these sequences are even more prevalent distal
of a TSS. Still, it does provide in part an explanation for absence
of TSS-centered OTX2-binding peaks.
It remains to be determined what guides OTX2 binding to a
motif in the genome. One possible explanation is that not all
binding sites are accessible. Epigenetic markers, such as DNA
methylation, or packed DNA structure might reduce the affinity or
availability of a motif for binding. This could explain the absence
of OTX2 binding in Alu repeats in promoter regions. Further-
more, competition of different transcription factors to bind in the
same genomic region may explain why not all motifs show OTX2
binding. For example, ETS1 and E2F compete in MYC promoter
binding. Only after mutation of the E2F site, ETS1 binding could
be detected [41]. Alternatively, OTX2 binding could be very
transient and may require additional factors to stably bind to
DNA. Epigenetic markers associated with activated genes
expression or the presence of other components of the transcrip-
tion complex might be necessary to facilitate its binding.
The binding characteristics of OTX2 raise the question,
whether OTX2 only has classical transcription factor function.
For other highly expressed transcription factors with frequent
binding, like MYC, additional epigenetic functions have been
described. Peng et al. suggested that OTX2, like CRX, might
recruit HAT-containing co-activators such as CBP, P300, and
GCN5 via direct interaction with ATXN7 to promote histone
acetylation [42,43]. Unfortunately direct evidence was not shown.
However, for the homologue ATXN1 interaction was shown in a
yeast2hybrid experiment [44]. ATXN7 is highly expressed in
medulloblastoma tumors and cell lines. OTX2 may function in a
similar way in promoting epigenetic changes. With this concept in
mind, the similarities between the bi-modal distribution of OTX2
and those of histone modifications such as H3K4me3 and
H3K9ac, both marks for active gene expression, could hint to a
direct role of OTX2 in histone modification [45,46].
Materials and Methods
ChIP-on-chip
D425 medulloblastoma cells were cultured in MEM medium
(Invitrogen, Carlsbad, CA), supplemented with 10% fetal bovine
serum, 0.1 mM MEM non essential amino acids, 200 mM
glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin
(Invitrogen) at 37uC in a humified atmosphere containing 5%
CO2. Two days after plating, cells were cross-linked with 1%
formaldehyde for 109. After washing, cells were incubated for 59 in
swelling buffer (5 mM PIPES, 85 mM KCl, 0.5% NP40) and
passed through a 23G needle. Isolated nuclei were lysed for 109 in
1 M Tris-HCl/1% SDS/0.5 M EDTA pH 8 on ice. Lysates were
sonicated on ice 76250 at 30 mA. 3 mL sample was diluted 1:10
in 1% TritonX-100/150 mM NaCl/50 mM Tris-HCl/2 mM
EDTA and cleared for 309 with 40 mL protein A agarose (Roche)
and 125 mL 10 mg/mL haring sperm DNA (Roche Applied
Sciences, Basel, Switzerland). 30 mL MYC antibody (Abcam,
Cambridge, MA) with 40 mL beads were added to cleared samples
and thumbled overnight in cold room. The next day beads were
sequentially washed with 0.1% SDS/1% TritonX-100/150 mM
NaCl/20 mM Tris-HCl/2 mM EDTA, with the same solution
with 500 mM NaCl, with 1% Deoxycholate, 1% NP40/250 mM
LiCl/10 mM Tris-HCl/2 mM EDTA and finally with 10 mM
Tris-HCl/10 mM EDTA. DNA was eluted in 500 mL 100 mM
NaHCO3/1% SDS. 20 mL 5 M NaCl was added before
decrosslinking at 65uC for 4 h. Next 10 mL 0.5 M EDTA,
20 mL 1 M Tris-HCl pH 6.5 and 2 mL 10 mg/mL Prot K
(Roche) were added and incubated at 45uC for 1 h to degrade
protein. RNA was degraded by adding 5 mL 10 mg/mL Rnase A
(Roche) and incubating for 309 at 37uC. DNA was purified using
Qiagen PCR purification kit (Qiagen, Germantown DE) and
quantified with Quant-IT Picogreen (Invitrogen).
The recovered DNA was amplified for labeling as described
previously [28]. Labeling of the material, hybridization to the
2.1 M Deluxe Promoter Array, scanning of the arrays and peak
calling were performed by Nimblegen, Inc. The ChIP-on-chip
experiments with OTX2 in D425, MED8A and DAOY cells were
previously published [8,9].
Data analyses
All data were scaled as
2log signal ratios by the Nimblegen
algorithm (Nimblegen) and mapped to transcription start sites
(TSSs) in the genome. If a gene has multiple promoter regions,
TSSs with less than 150 bp spacing from the previous were
discarded. All remaining promoter regions were aligned and the
average
2log binding signal was calculated over 50 bp bins relative
OTX2 and MYC Binding Links to High Gene Expression
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manufacturer’s algorithm. Graphs of the average
2log signals and
the percentage of peaks as a function of the distance to the TSS
were generated in R2 (http://r2.amc.nl). Heatmaps of signals for
an individual promoter region were generated in TMEV [47].
Only data of promoter regions with more than 100 bins with
informative data within 25000 bp to 3000 bp were included. The
promoter regions were sorted based on the expression of the
corresponding gene in D425 cells (GSE22875) [8].
Promoter regions harboring at least one binding peak with its
center overlapping the region of 22000 to 2000 bp surrounding
the TSS, were defined as bound by OTX2 or MYC. Distance
between OTX2- and MYC-binding peak centers were calculated
for all single OTX2-bound promoter regions. The expected
distance between OTX2- and MYC-binding peak centers was
generated by randomizing all OTX2-binding peak locations in
regards to the TSS locations in Excel and taking the average over
3 randomizations. The percentage of OTX2-binding peaks within
different distance ranges was plotted for the calculated and
expected values. A Fisher’s exact test was used for determining
significant changes.
All promoter regions were classified based on the combination
of OTX2 and MYC binding within the 22000 bp and 2000 bp
region. The average expression of genes within these classes was
calculated using data of D425 cells (GSE22875), 10 primary non-
WNT/non-SHH medulloblastoma with both high OTX2 and
MYC expression (GSE10327 and GSE12992), 9 normal cerebel-
lum samples (GSE3526) and undifferentiated human embryonal
cells (GSE9921). Gene set enrichment analyses were performed
using the DAVID tool (http://david.abcc.ncifcrf.gov/) and
BROAD tool (http://www.broadinstitute.org/gsea) [31–33].
Binding motif discovery and genome distribution
The program DME (v2.0) was employed using the hybrid mode
to identify enriched DNA-sequence motifs of length 6, 7 or 8 in the
peaks, when compared to a background of peak-flanking
sequences [29]. The sequences used to build the best scoring
motif were masked in the peak sequences and DME was run again
using the same settings. This procedure was repeated 15 times.
The main DNA-binding sequences for OTX2 (TAATCC,
TAAGCC and TAATCT) and the E-box sequences were aligned
to the UCSC hg18. Their frequencies were plotted in relation to
their distance to either a OTX2- and MYC-binding peak center or
a TSS. To identify relations between the presence of a DNA-
binding sequence and gene expression, all peaks were sorted by the
expression level of the associated genes. After binning per 400
peaks, the motif frequencies and the average expression levels were
calculated per bin and plotted.
Supplementary M&M
Western blotting and antibodies used were as previously
described [9].
Supporting Information
Figure S1 Immunoprecipitation of OTX2 and MYC in
medulloblastoma cells. Western blot analyses of immunopre-
cipitation of OTX2 and MYC in D425 medulloblastoma cells as
well as OTX2 in MED8A and DAOY cells with induced OTX2
expression.
(TIFF)
Figure S2 OTX2-binding distribution in relation to
MYC binding. All promoter regions of the class with single
OTX2-binding peak and MYC binding were sorted by the
location of the first upstream MYC-binding peak. To assess the
relation between MYC and OTX2 binding, the promoter regions
were binned per 400 promoter regions, except for the last bin
(517). Per bin, the average OTX2- and MYC-binding signals were
calculated in regards to the TSS, normalized to 1 and depicted as
a panel. The OTX2-binding signal coincides with the MYC, when
the MYC binding signal becomes more proximal to the TSS.
(TIFF)
Table S1 Enrichment of binding motifs in ChIP exper-
iments.
(XLS)
Table S2 Gene enrichment analyses.
(XLS)
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